Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia.
about
Current Strategies for the Detection of Minimal Residual Disease in Childhood Acute Lymphoblastic LeukemiaMinimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologiesDevelopment-associated immunophenotypes reveal the heterogeneous and individualized early responses of adult B-acute lymphoblastic leukemia.Proposal for the standardization of flow cytometry protocols to detect minimal residual disease in acute lymphoblastic leukemiaDetection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH.Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia.Detection of minimal residual disease in pediatric acute lymphoblastic leukemia.Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia.Minimal Residual Disease in Acute Lymphoblastic Leukemia: How to Recognize and Treat It.Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis.A QA program for MRD testing demonstrates that systematic education can reduce discordance among experienced interpreters.Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients.Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.Major impact of an early bone marrow checkpoint (day 21) for minimal residual disease in flow cytometry in childhood acute lymphoblastic leukemia.Minimal residual disease detection of leukemic cells in ovarian cortex by eight-color flow cytometry.Clinical utility of next-generation sequencing-based minimal residual disease in paediatric B-cell acute lymphoblastic leukaemia.Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia.Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL.TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype.
P2860
Q26751269-26DD1F63-6BC3-4954-BDB4-F7A2CCBB5B69Q26828511-F221B9F7-3ABD-41ED-AAB7-6174BB94561BQ33590468-9E22A453-144B-4A1F-8096-0A45F2B1B2E2Q36371093-B206E08F-CE00-4FD0-ABEF-B0AE195FA459Q37481981-249A2BFF-80ED-4D11-8768-1EA41E0DB1C4Q37624584-085929A7-686D-4395-BB34-E4CDAD71D956Q38113738-4E97999F-C58E-468B-9FDE-70B70CAC3694Q38681322-E5D86BAE-BEB3-4C63-BD02-4550B08C736AQ38756821-39051886-22E1-491A-8161-74AE23C09C0EQ38792016-6A1D60EE-027F-4B65-A516-FDE0158688C3Q38802404-90BDEB13-E4F8-4891-90D3-67CC24BA24E7Q38815331-58485EAF-3784-4DC3-9425-D72C3B178CD2Q39035188-EED0FA22-FDAE-4175-BA1C-FE335A6C27AEQ40910460-1BF97E0A-3D95-409E-B33B-A1A598351DBAQ41246402-A9294E16-4426-4889-BCD2-1C561B8E6153Q44303548-27D6433B-7713-48D9-A58C-057486F36456Q50223693-76470532-2691-429F-A2B8-ABCE60344095Q50922836-62E6A324-12E2-467E-86DD-34132B6CBC8FQ51660064-F0FCC796-C1CD-44DE-B3A0-3E0E0D598D3AQ52735368-71FAE46A-F4E6-4937-B602-75DA8A64EA5CQ52877127-9EB3AF9B-ED43-4B66-93BC-1E13C49B4F6A
P2860
Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Time point-dependent concordan ...... acute lymphoblastic leukemia.
@ast
Time point-dependent concordan ...... acute lymphoblastic leukemia.
@en
type
label
Time point-dependent concordan ...... acute lymphoblastic leukemia.
@ast
Time point-dependent concordan ...... acute lymphoblastic leukemia.
@en
prefLabel
Time point-dependent concordan ...... acute lymphoblastic leukemia.
@ast
Time point-dependent concordan ...... acute lymphoblastic leukemia.
@en
P2093
P2860
P1433
P1476
Time point-dependent concordan ...... acute lymphoblastic leukemia.
@en
P2093
Alessandra Benetello
Andre Schrauder
Andrea Biondi
Angela Schumich
Barbara Buldini
Daniela Silvestri
Giovanni Cazzaniga
Giuseppe Basso
Giuseppe Gaipa
Leonid Karawajew
P2860
P304
P356
10.3324/HAEMATOL.2011.060426
P577
2012-05-11T00:00:00Z